# Aardvark Therapeutics, Inc. (AARD) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Aardvark Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AARD/mda/fy2025/): filed 2026-03-23; accession 0001193125-26-119770 (https://www.sec.gov/Archives/edgar/data/1774857/000119312526119770/ck0001774857-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AARD/mda/fy2024/): filed 2025-03-31; accession 0000950170-25-047835 (https://www.sec.gov/Archives/edgar/data/1774857/000095017025047835/aard_10k_20241231.htm)

Back to /company/AARD/